1293P IMpower150: Updated efficacy analysis in patients with EGFR mutations
Martin Reck, Tony Mok, Mark A. Socinski, Robert M. Jotte, Wan‐Teck Lim, Federico Cappuzzo, Francesco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez‐Abreu, Denis Moro‐Sibilot, C.A. Thomas, Fabrice Barlési, Gene Grant Finley, G. Shankar, Wenhui Yu, David M. Merritt, Makoto Nishio
Topics & Concepts
MedicineAtezolizumabInternal medicineBevacizumabPopulationOncologyTolerabilityCarboplatinNivolumabCancerChemotherapyImmunotherapyAdverse effectEnvironmental healthCisplatinCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsCAR-T cell therapy research